Literature DB >> 32184130

Mapping the incidence of the COVID-19 hotspot in Iran - Implications for Travellers.

Zahra Arab-Mazar1, Ranjit Sah2, Ali A Rabaan3, Kuldeep Dhama4, Alfonso J Rodriguez-Morales5.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32184130      PMCID: PMC7118655          DOI: 10.1016/j.tmaid.2020.101630

Source DB:  PubMed          Journal:  Travel Med Infect Dis        ISSN: 1477-8939            Impact factor:   6.211


× No keyword cloud information.
Dear Editor After the first two months of the epidemics of Coronavirus Disease 2019 (COVID-19) in the world [1,2], caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), multiple epidemiological assessments in countries from Asia, Pacific, Europe, and North America have been published [3,4]. Nevertheless, there are countries, with a rapid increase and a high number of cases, with a lack of studies. This is the case of Iran in the Middle East. For these reasons, we have developed epidemiological maps of cases but also of incidence rates using official populations, by provinces, for COVID-19 in Iran using geographical information systems (GIS). Surveillance cases data from February 19 to March 9, 2020, officially reported by the Iranian health authorities were used to estimate the cumulated incidence rates using reference population data on SARS-CoV-2 confirmed infections (cases/100,000 pop) and to develop the maps by provinces, using the GIS software Kosmo® 3.1. During the first 20 days of epidemics, 7161 cases of COVID-19 were reported in the country, for a cumulated rate of 8.9 cases/100,000 population, reaching up to 1234 cases during March 6, 2020 (Fig. 1 ). All the provinces have been affected, and rates ranged from 0.8 (Boushehr) to 61.8 cases/100,000 population (Qom) (Fig. 1). At Qom, the first two cases were reported. COVID-19 arrived at Iran from China. The highest number of cases have been reported in Tehran, 1945 (Fig. 1), followed by Qom, 712, and by Mazandaran, with 633. Qom is the border with Markazi and Semnan, provinces with rates from 27.2 to 34.9 cases/100,000 population. From the GIS-based maps, it is clear that spreading in the country is occurring from north-central provinces such as Tehran and Qom. Till March 9, 2020, there have been 237 deaths (3.31%, case fatality rate). While the number of cases seems to decrease during the last three days, this is not occurring with fatalities (Fig. 1).
Fig. 1

COVID-19 situation in Iran, February 19 to March 9, 2020. A. Number of cases and deaths. B. Case distribution by provinces. C. Incidence rates, cases/100,000 population by provinces.

COVID-19 situation in Iran, February 19 to March 9, 2020. A. Number of cases and deaths. B. Case distribution by provinces. C. Incidence rates, cases/100,000 population by provinces. Iran is the third country with the highest number of reported COVID-19 cases after China, and Italy, up to March 16, 2020 with 14,991 cases, being the first in the Middle East region, and maybe becoming a significant source of imported cases in this area, in countries such as Iraq, Afghanistan, and Pakistan, among others. While the highest number of COVID-19 cases has been reported in the capital city, using GIS and estimating the incidence/attack rates per province, that one is placed as the seventh, having more cases per population at Qom, Semnan, and Markazi, among other provinces (Fig. 1). A recent study, based on imported cases from Iran, estimated that 18,300 (95% confidence interval: 3770 to 53,470) COVID-19 cases would have had to occur in the country [5], assuming an outbreak duration of 1.5 months. Even if it were considered that all imported cases of Iran were identified in all states with certainty, the “best case” outbreak size was substantial (1820, 95% CI: 380–5320 cases), and far higher than reported case counts in February 2020. All confirmed cases in Saudi Arabia are imported from Iran and one from Iraq and other cases are close contacts to those confirmed cases. Imported cases from Iran have been diagnosed at Kuwait, Bahrain, Iraq, Oman, Qatar, among other Asiatic countries, but also Georgia, Estonia, Belarus, and even New Zealand [6]. The capital city of Khorasan Razavi (3.1 cases/100,000 population), Mashhad, is the second-largest holy city in the world, attracting more than 20 million tourists and pilgrims every year [7,8], many of whom come to pay homage to the Imam Reza shrine (the eighth Shi'ite Imam). Regardless of this epidemiological scenario, the Iran outbreak of COVID-19 is still beginning and complex. Authorities have limited travel, and schools and universities have closed, as also have occurred in Italy and Spain, until the start of the holiday for Persian new year Nowruz on March 20, 2020, as measures for spreading of this coronavirus [7]. As there are severe limitations in the medical supplies available in the Iranian public health system to deal with the current SARS-CoV-2 outbreak, international support, additionally to be provided from the World Health Organization, is needed in the country to mitigate the impacts of this epidemic, and to avoid additional spreading. For the moment of the proofs correction of this article, Iran reached 14,991 cases, of them 3,774 in Tehran, 1,301 in Esfahan, and 1,023 in Qom (March 16, 2020).

Credit

AJRM, Conceptualization; Data curation; Formal analysis; Methodology; Software; Writing - original draft; Writing - review & editing. ZAM, Data curation; Formal analysis; Methodology; Writing - review & editing. RS, Writing - review & editing. AAR, Writing - review & editing. KD, Writing - review & editing.

Declaration of competing interest

We declare that we have no competing interests.
  8 in total

1.  History is repeating itself: Probable zoonotic spillover as the cause of the 2019 novel Coronavirus Epidemic

Authors:  Alfonso J Rodriguez-Morales; D Katterine Bonilla-Aldana; Graciela Josefina Balbin-Ramon; Ali A Rabaan; Ranjit Sah; Alberto Paniz-Mondolfi; Pasquale Pagliano; Silvano Esposito
Journal:  Infez Med       Date:  2020-03-01

2.  The first 2019 novel coronavirus case in Nepal.

Authors:  Anup Bastola; Ranjit Sah; Alfonso J Rodriguez-Morales; Bibek Kumar Lal; Runa Jha; Hemant Chanda Ojha; Bikesh Shrestha; Daniel K W Chu; Leo L M Poon; Anthony Costello; Kouichi Morita; Basu Dev Pandey
Journal:  Lancet Infect Dis       Date:  2020-02-10       Impact factor: 25.071

3.  Travellers give wings to novel coronavirus (2019-nCoV).

Authors:  Mary E Wilson; Lin H Chen
Journal:  J Travel Med       Date:  2020-03-13       Impact factor: 8.490

4.  COVID-19 - the role of mass gatherings.

Authors:  Shahul H Ebrahim; Ziad A Memish
Journal:  Travel Med Infect Dis       Date:  2020-03-09       Impact factor: 6.211

5.  COVID-19: preparing for superspreader potential among Umrah pilgrims to Saudi Arabia.

Authors:  Shahul H Ebrahim; Ziad A Memish
Journal:  Lancet       Date:  2020-02-27       Impact factor: 79.321

6.  An interactive web-based dashboard to track COVID-19 in real time.

Authors:  Ensheng Dong; Hongru Du; Lauren Gardner
Journal:  Lancet Infect Dis       Date:  2020-02-19       Impact factor: 25.071

7.  Going global - Travel and the 2019 novel coronavirus.

Authors:  Alfonso J Rodríguez-Morales; Kirsten MacGregor; Sanch Kanagarajah; Dipti Patel; Patricia Schlagenhauf
Journal:  Travel Med Infect Dis       Date:  2020-02-08       Impact factor: 6.211

8.  Estimation of Coronavirus Disease 2019 (COVID-19) Burden and Potential for International Dissemination of Infection From Iran.

Authors:  Ashleigh R Tuite; Isaac I Bogoch; Ryan Sherbo; Alexander Watts; David Fisman; Kamran Khan
Journal:  Ann Intern Med       Date:  2020-03-16       Impact factor: 25.391

  8 in total
  41 in total

Review 1.  Coronavirus Disease 2019-COVID-19.

Authors:  Kuldeep Dhama; Sharun Khan; Ruchi Tiwari; Shubhankar Sircar; Sudipta Bhat; Yashpal Singh Malik; Karam Pal Singh; Wanpen Chaicumpa; D Katterine Bonilla-Aldana; Alfonso J Rodriguez-Morales
Journal:  Clin Microbiol Rev       Date:  2020-06-24       Impact factor: 26.132

2.  Nurses' lived experiences of caring for patients with COVID-19: a phenomenological study.

Authors:  Nastaran Heydarikhayat; Nezar Ghanbarzehi; Zarkhatoon Shahkaramzehi; Kimya Sabagh; Camelia Rohani
Journal:  J Res Nurs       Date:  2022-07-08

3.  Measuring the customer satisfaction of public transportation in Tehran during the COVID-19 pandemic using MCDM techniques.

Authors:  Amir Shabani; Alireza Shabani; Bahareh Ahmadinejad; Ali Salmasnia
Journal:  Case Stud Transp Policy       Date:  2022-05-13

4.  Spatio-temporal analysis of COVID-19 incidence rate using GIS: a case study-Tehran metropolitan, Iran.

Authors:  R Nasiri; S Akbarpour; A R Zali; N Khodakarami; M H Boochani; A R Noory; H Soori
Journal:  GeoJournal       Date:  2021-05-12

5.  Lymphopenia and lung complications in patients with coronavirus disease-2019 (COVID-19): A retrospective study based on clinical data.

Authors:  Ehsan Zaboli; Hadi Majidi; Reza Alizadeh-Navaei; Akbar Hedayatizadeh-Omran; Hossein Asgarian-Omran; Laleh Vahedi Larijani; Vahid Khodaverdi; Omolbanin Amjadi
Journal:  J Med Virol       Date:  2021-05-13       Impact factor: 20.693

6.  Management of Spine Trauma in COVID-19 Pandemic: A Preliminary Report.

Authors:  Mohammadreza Chehrassan; Adel Ebrahimpour; Hasan Ghandhari; Morteza Sanei Taheri; Bahador Athari; Mehrdad Sadighi; Meisam Jafari KafiAbadi; Amin Karami; Alireza Zali
Journal:  Arch Bone Jt Surg       Date:  2020-04

Review 7.  Progression and Trends in Virus from Influenza A to COVID-19: An Overview of Recent Studies.

Authors:  Hakimeh Baghaei Daemi; Muhammad Fakhar-E-Alam Kulyar; Xinlin He; Chengfei Li; Morteza Karimpour; Xiaomei Sun; Zhong Zou; Meilin Jin
Journal:  Viruses       Date:  2021-06-15       Impact factor: 5.048

8.  Epidemiological characteristics and initial spatiotemporal visualisation of COVID-19 in a major city in the Middle East.

Authors:  Shahab MohammadEbrahimi; Alireza Mohammadi; Robert Bergquist; Fatemeh Dolatkhah; Mahsa Olia; Ayoub Tavakolian; Elahe Pishgar; Behzad Kiani
Journal:  BMC Public Health       Date:  2021-07-12       Impact factor: 3.295

9.  Risk perception and adherence to preventive behaviours related to the COVID-19 pandemic: a community-based study applying the health belief model.

Authors:  Aziz Kamran; Khatereh Isazadehfar; Heshmatolah Heydari; Ramin Nasimi Doost Azgomi; Mahdi Naeim
Journal:  BJPsych Open       Date:  2021-07-13

10.  Gender Differences in Anxiety, Depression, and Nursing Needs Among Isolated Coronavirus Disease 2019 Patients.

Authors:  Yifei Li; Juan Li; Zhen Yang; Jie Zhang; Lili Dong; Fusheng Wang; Jingping Zhang
Journal:  Front Psychol       Date:  2021-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.